Phasebio Pharmaceuticals Inc (PHAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAS | LABT | GNPX | ||
| Company | Phasebio Pharmaceuticals Inc | Lakewood-Amedex Biotherapeutics Inc | Genprex Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.0800 | 2.00 | 5.06 | ||
| High | 0.0920 | 2.24 | 5.46 | ||
| Low | 0.0665 | 1.95 | 4.65 | ||
| Last | 0.0701 | 2.16 | 4.75 | ||
| Change | -0.0249 | +0.14 | -1.24 | ||
| Percent Change | -26.21% | +6.93% | -20.70% | ||
| Volume | 9,647,400 | 240,400 | 2,817,800 | ||
| 20-Day Average Volume | 3,930,150 | 4,289,700 | 176,272 | ||
| Previous | 0.0950 | 2.02 | 5.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.1610 | 2.35 | 8.85 | ||
| 20-Day Raw Stochastic | 2.27% | 9.63% | 1.00% | ||
| 20-Day Relative Strength | 20.88 | 22.00 | 28.02 | ||
| Weighted Alpha | -91.26 | N/A | -96.70 | ||
| Today's Opinion | 100% Sell | N/A | 100% Sell | ||
| Yesterday's Opinion | 100% Sell | N/A | 100% Sell | ||
| Last Month's Opinion | 72% Sell | N/A | 88% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -42.40% since 10/26/22 | -13.60% since 07/27/26 | -38.59% since 07/27/26 | ||
| Low | 0.0665 on 11/02/22 | 1.80 on 07/29/26 | 4.65 on 08/03/26 | ||
| High | 0.1440 on 10/27/22 | 2.50 on 07/28/26 | 8.27 on 07/28/26 | ||
| 1-Month | |||||
| %Chg | -60.17% since 09/30/22 | -21.45% since 07/02/26 | -62.52% since 07/02/26 | ||
| Low | 0.0665 on 11/02/22 | 1.66 on 07/17/26 | 4.65 on 08/03/26 | ||
| High | 0.2250 on 10/14/22 | 6.85 on 07/22/26 | 15.60 on 07/06/26 | ||
| 3-Month | |||||
| %Chg | -93.85% since 08/02/22 | -93.70% since 05/01/26 | -76.48% since 05/01/26 | ||
| Low | 0.0665 on 11/02/22 | 1.66 on 07/17/26 | 4.65 on 08/03/26 | ||
| High | 1.3800 on 08/09/22 | 34.00 on 05/07/26 | 22.00 on 05/04/26 | ||
| 6-Month | |||||
| %Chg | -94.35% since 05/02/22 | N/A since 04/23/26 | -91.00% since 02/03/26 | ||
| Low | 0.0665 on 11/02/22 | 1.66 on 07/17/26 | 4.65 on 08/03/26 | ||
| High | 1.3800 on 08/09/22 | 98.20 on 04/23/26 | 57.40 on 02/24/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,495 | 3,537 | 3,025 | ||
| Shares Outstanding, K | 49,858 | 1,751 | 505 | ||
| Annual Sales, $M | 10,830,000 | 0 | 0 | ||
| Annual Net Income, $M | -131,070,000 | -3,850,000 | -16,230,000 | ||
| Last Qtr Sales, $M | 210,000 | 0 | 0 | ||
| Last Qtr Income, $M | -16,670,000 | -920,000 | -4,460,000 | ||
| 60-Month Beta | 2.57 | N/A | -0.92 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 08/12/22 | -2.00 on 05/22/26 | -14.07 on 05/13/26 | ||
| Latest Earnings Date | 11/09/22 | 08/28/26 | 08/13/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividend Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||